Trial intelligence / Profile preview

Albumin in cardiac surgery

2015-002556-27Phase 4Completed

Sponsor
Helsinki University Hospital
Start
Nov 2016
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial of albumin (human) and ringer's acetate in Cardiovascular collapse and complications of surgical procedures (3 arms), sponsored by Helsinki University Hospital. Primary endpoint: Composite major postoperative adverse outcome. Started Nov 2016; status: completed.

02

Drugs

albumin (human)ringer's acetate
03

Conditions

Cardiovascular collapsecomplications of surgical procedures

Beyond the preview

Go deeper on 2015-002556-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-002556-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call